Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms.

Scientific reports - 6 Jul 2021

Kranjec Christian, Kristensen Sofie S, Bartkiewicz Karolina T, Brønner Mikkel, Cavanagh Jorunn P, Srikantam Aparna, Mathiesen Geir, Diep Dzung B

Abstract excerpt

Bacteriocins are ribosomally-synthesized antimicrobial peptides, showing great potential as novel treatment options for multidrug-resistant pathogens. In this study, we designed a novel hybrid bacteriocin, Hybrid 1 (H1), by combing the N-terminal part and the C-terminal part of the related bacteriocins enterocin K1 (K1) and enterocin EJ97 (EJ97), respectively. Like the parental bacteriocins, H1 used the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Bacteriocins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biofilms

Share to Drug Resistance, Bacterial

Share to Genes, Bacterial

Share to Microbial Sensitivity Tests

Share to Models, Biological

Share to Whole Genome Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 34230527
DOI: 10.1038/s41598-021-93158-z
PMCID: PMC8260761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms.PMID 34230527Read ↗

The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogensSemantic proximity Read ↗

Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall AlterationsSemantic proximity Read ↗

<b> A novel enterococcus phage endolysin Lys22 with a wide host range against mixed biofilm of <i>Enterococcus faecalis</i> , <i>Staphylococcus aureus</i> and <i>Acinetobacter baumannii</i> </b>Semantic proximity Read ↗

Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strainsSemantic proximity Read ↗

Synergistic Antimicrobial Activity of Epinecidin-1 and Its Variants with Antibiotics Against Nosocomial Pathogens: Implications for In Vivo Wound HealingSemantic proximity Read ↗

Garvicin-SHAMU-LG6, A Novel Bacteriocin from Lactococcus garvieae That Exert Broad Antimicrobial Activity Against Drug-Resistant PathogensSemantic proximity Read ↗

Staphylococcal Biofilms: Challenges and Novel Therapeutic PerspectivesSemantic proximity Read ↗

Synergistic Antimicrobial Activity of Epinecidin-1 and Ats Variants with Antibiotics Against Noso-Comial Pathogens: Implications for In Vivo Wound HealingSemantic proximity Read ↗

Rational design of short hybrid Cecropin B/Aurein 1.2 peptide analogues: in vitro synergistic anti-MRSA and anti-biofilm activitiesSemantic proximity Read ↗

Bactericidal activity of newly synthesized antimicrobial peptides against methicillin-resistant staphylococcus aureus and biofilm-forming methicillin-resistant staphylococcus aureusSemantic proximity Read ↗

Coagulase-Negative Staphylococci phages panorama: Genomic diversity and in vitro studies for a therapeutic use.Semantic proximity Read ↗

Genomic Analysis of Bacteriocin-Producing Staphylococci: High Prevalence of Lanthipeptides and the Micrococcin P1 Biosynthetic Gene ClustersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.